Showing results (401-410 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|January 1, 1992
Standardized mouse infection models as a way of evaluating the potency of anti-infectious agentsB Bizzini, M Fattal-GermanDevelopments in Biological Standardization|January 1, 1992
Immunomodulators and primary prevention of respiratory infections: methodological considerationsJ P ColletDevelopments in Biological Standardization|January 1, 1992
Recent progress in immunopharmacology and therapeutic effects of polysaccharidesG ChiharaDevelopments in Biological Standardization|January 1, 1992
Stability of BCG vaccine (intravesical) Theracys/BCG therapeutic ImmuCyst and its importance in clinical efficacyJ Sparkes, N Guest, Z Csizer, et al.Developments in Biological Standardization|January 1, 1992
Oral administration of immunomodulators and the mucosal immune systemJ P Revillard, G Cozon, C CzerkinskyDevelopments in Biological Standardization|January 1, 1992
C-fos and c-myc modulation, mitogenic effect and Ia expression in the P388D1 murine macrophage line treated by immunomodifiersM M Teyssier, Y C Le Garrec, E H Jullian, et al.Developments in Biological Standardization|January 1, 1986
The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattleT W Pay, P J HingleyDevelopments in Biological Standardization|January 1, 1986
Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animalsJ M Wood, J Mumford, G C Schild, et al.Developments in Biological Standardization|January 1, 1986
Evaluation of a combined measles-mumps-rubella-chickenpox vaccineM Just, R Berger, V JustDevelopments in Biological Standardization|January 1, 1985
The immortalization of human lymphocytes by spheroplast fusionH Brzeski, M Chambers, C MacDonald, et al.Pageof 220